BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1701 related articles for article (PubMed ID: 11294822)

  • 1. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
    Pearson G; Robinson F; Beers Gibson T; Xu BE; Karandikar M; Berman K; Cobb MH
    Endocr Rev; 2001 Apr; 22(2):153-83. PubMed ID: 11294822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffolding and protein interactions in MAP kinase modules.
    Karandikar M; Cobb MH
    Cell Calcium; 1999 Nov; 26(5):219-26. PubMed ID: 10643560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches.
    Whitmarsh AJ; Davis RJ
    Sci STKE; 1999 Sep; 1999(1):PE1. PubMed ID: 11865181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaffold proteins in mammalian MAP kinase cascades.
    Yoshioka K
    J Biochem; 2004 Jun; 135(6):657-61. PubMed ID: 15213240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the control of MAP kinase pathways.
    English J; Pearson G; Wilsbacher J; Swantek J; Karandikar M; Xu S; Cobb MH
    Exp Cell Res; 1999 Nov; 253(1):255-70. PubMed ID: 10579927
    [No Abstract]   [Full Text] [Related]  

  • 8. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
    Carvalheira JB; Calegari VC; Zecchin HG; Nadruz W; Guimarães RB; Ribeiro EB; Franchini KG; Velloso LA; Saad MJ
    Endocrinology; 2003 Dec; 144(12):5604-14. PubMed ID: 12960006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mitogen- and stress-activated kinases in ischemic injury.
    Irving EA; Bamford M
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):631-47. PubMed ID: 12045661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation and properties of MAPKs.
    Raman M; Chen W; Cobb MH
    Oncogene; 2007 May; 26(22):3100-12. PubMed ID: 17496909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of MAP kinases: insights from gene-targeting studies.
    Kuida K; Boucher DM
    J Biochem; 2004 Jun; 135(6):653-6. PubMed ID: 15213239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.
    Johnson GL; Lapadat R
    Science; 2002 Dec; 298(5600):1911-2. PubMed ID: 12471242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Katiyar SK; Afaq F; Azizuddin K; Mukhtar H
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):110-7. PubMed ID: 11601887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining mitogen-activated protein kinase pathways with mass spectrometry-based approaches.
    Powell DW; Pierce WM; McLeish KR
    Mass Spectrom Rev; 2005; 24(6):847-64. PubMed ID: 15619233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways.
    Zhang W; Chen T; Wan T; He L; Li N; Yuan Z; Cao X
    Biochem Biophys Res Commun; 2000 Aug; 274(3):872-9. PubMed ID: 10924369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle.
    Smythe GM; Forwood JK
    Muscle Nerve; 2012 Sep; 46(3):374-83. PubMed ID: 22907228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
    Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
    Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.
    Saxena M; Williams S; Taskén K; Mustelin T
    Nat Cell Biol; 1999 Sep; 1(5):305-11. PubMed ID: 10559944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.